Page last updated: 2024-09-04

naproxen and Disease Exacerbation

naproxen has been researched along with Disease Exacerbation in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (35.71)29.6817
2010's7 (50.00)24.3611
2020's2 (14.29)2.80

Authors

AuthorsStudies
Grubbs, CJ; Juliana, MM; Lubet, RA; Miller, MS; Moeinpour, FL; Mohammed, A; Sei, S; Shoemaker, RH; Suen, CS1
Brown, MT; Carrino, JA; Fountaine, RJ; Guermazi, A; Hickman, A; Hochberg, MC; Nakajo, S; Pixton, G; Schnitzer, TJ; Verburg, KM; Viktrup, L; Walsh, DA; West, CR; White, A1
McClain, SA; Singer, AJ; Towery, H1
Abuowda, Y; Craveiro, N; Mestre, A; Oliveira, AA; Pedro, F; Santos, C1
Baltinas, J; McCluskey, P; Weaver, T; Zagora, S1
Breitner, J; Etienne, P; Lafaille-Magnan, ME; Leoutsakos, J; Madjar, C; Meyer, PF; Poirier, J; Rosa-Neto, P; Savard, M; Tremblay-Mercier, J1
Karceski, S1
Almon, RR; DuBois, DC; Jusko, WJ; Li, X1
Abram, F; Choquette, D; Dorais, M; Haraoui, B; Martel-Pelletier, J; Pelletier, JP; Raynauld, JP; Wildi, LM1
Aisen, PS; Davis, KL; Farlow, MR; Grundman, M; Jin, S; Pfeiffer, E; Sano, M; Schafer, KA; Thal, LJ; Thomas, RG1
Czap, A1
Balestra, V; Molfetta, G; Monteforte, P; Rovetta, G2
Bierma-Zeinstra, SM; Hazes, JM; Koes, BW; Pols, HA; Reijman, M; Stricker, BH1

Trials

6 trial(s) available for naproxen and Disease Exacerbation

ArticleYear
Long-Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial.
    Arthritis & rheumatology (Hoboken, N.J.), 2021, Volume: 73, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Blocking; Antibodies, Monoclonal, Humanized; Celecoxib; Diclofenac; Disease Progression; Double-Blind Method; Female; Fractures, Bone; Fractures, Spontaneous; Humans; Injections, Subcutaneous; Intra-Articular Fractures; Male; Middle Aged; Naproxen; Nerve Growth Factor; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteonecrosis; Treatment Outcome

2021
INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.
    Neurology, 2019, 04-30, Volume: 92, Issue:18

    Topics: Aged; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Double-Blind Method; Female; Humans; Male; Middle Aged; Naproxen; Prodromal Symptoms; Treatment Outcome

2019
Risk factors predictive of joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observation.
    Annals of the rheumatic diseases, 2011, Volume: 70, Issue:8

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Knee; C-Reactive Protein; Disease Progression; Epidemiologic Methods; Female; Humans; Knee Joint; Magnetic Resonance Imaging; Male; Menisci, Tibial; Middle Aged; Naproxen; Osteoarthritis, Knee; Prognosis; Pyrroles; Tibial Meniscus Injuries

2011
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.
    JAMA, 2003, Jun-04, Volume: 289, Issue:21

    Topics: Activities of Daily Living; Aged; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Progression; Double-Blind Method; Female; Humans; Isoenzymes; Lactones; Male; Membrane Proteins; Naproxen; Neuropsychological Tests; Proportional Hazards Models; Prostaglandin-Endoperoxide Synthases; Regression Analysis; Sulfones; Treatment Outcome

2003
A two-year study of chondroitin sulfate in erosive osteoarthritis of the hands: behavior of erosions, osteophytes, pain and hand dysfunction.
    Drugs under experimental and clinical research, 2004, Volume: 30, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Chondroitin Sulfates; Disease Progression; Drug Therapy, Combination; Female; Finger Joint; Hand Deformities, Acquired; Humans; Male; Middle Aged; Naproxen; Osteoarthritis; Pain; Prospective Studies; Radiography; Severity of Illness Index; Treatment Outcome

2004
Chondroitin sulfate in erosive osteoarthritis of the hands.
    International journal of tissue reactions, 2002, Volume: 24, Issue:1

    Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Chondroitin Sulfates; Disease Progression; Drug Therapy, Combination; Female; Finger Joint; Humans; Male; Middle Aged; Naproxen; Osteoarthritis; Prospective Studies; Radiography; Time Factors

2002

Other Studies

8 other study(ies) available for naproxen and Disease Exacerbation

ArticleYear
Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers.
    Cancer prevention research (Philadelphia, Pa.), 2020, Volume: 13, Issue:3

    Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Carcinogens; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Naproxen; Neoplasm Recurrence, Local; Neoplasms, Experimental; Pulse Therapy, Drug; Rats; Time Factors; Time-to-Treatment; Urinary Bladder; Urinary Bladder Neoplasms

2020
Effect of tadalafil on reduction of necrosis in the ischemic zone in a rat comb burn model.
    Burns : journal of the International Society for Burn Injuries, 2018, Volume: 44, Issue:6

    Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Burns; Disease Models, Animal; Disease Progression; Free Radical Scavengers; Ischemia; Naproxen; Necrosis; Random Allocation; Rats; Rats, Sprague-Dawley; Skin; Tadalafil; Vasodilator Agents

2018
Vasculitis of small and large vessels, a casual association?
    Revista da Associacao Medica Brasileira (1992), 2018, Volume: 64, Issue:7

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Disease Progression; Humans; Male; Naproxen; Recurrence; Vasculitis, Leukocytoclastic, Cutaneous

2018
Infective conjunctivitis progressing to posterior scleritis.
    Clinical & experimental ophthalmology, 2019, Volume: 47, Issue:6

    Topics: Adenovirus Infections, Human; Adenoviruses, Human; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Ceftriaxone; Chloramphenicol; Conjunctivitis, Viral; Disease Progression; Drug Therapy, Combination; Eye Infections, Viral; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Naproxen; Polymerase Chain Reaction; Prednisolone; Scleritis; Tomography, X-Ray Computed; Ultrasonography; Visual Acuity

2019
Can naproxen slow the progression of Alzheimer disease?
    Neurology, 2019, 04-30, Volume: 92, Issue:18

    Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Asymptomatic Diseases; Disease Progression; Humans; Naproxen

2019
Modeling Sex Differences in Pharmacokinetics, Pharmacodynamics, and Disease Progression Effects of Naproxen in Rats with Collagen-Induced Arthritis.
    Drug metabolism and disposition: the biological fate of chemicals, 2017, Volume: 45, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Disease Progression; Female; Injections, Intraperitoneal; Male; Models, Biological; Naproxen; Protein Binding; Rats, Inbred Lew; Serum Albumin; Severity of Illness Index; Sex Characteristics

2017
Pass the tablet please.
    Alternative medicine review : a journal of clinical therapeutic, 2003, Volume: 8, Issue:3

    Topics: Aged; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Ginkgo biloba; Humans; Lactones; Memory; Naproxen; Phytotherapy; Randomized Controlled Trials as Topic; Sulfones; Tablets

2003
Is there an association between the use of different types of nonsteroidal antiinflammatory drugs and radiologic progression of osteoarthritis? The Rotterdam Study.
    Arthritis and rheumatism, 2005, Volume: 52, Issue:10

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Disease Progression; Female; Follow-Up Studies; Humans; Ibuprofen; Logistic Models; Male; Middle Aged; Naproxen; Netherlands; Osteoarthritis, Hip; Osteoarthritis, Knee; Pharmacies; Piroxicam; Radiography; Risk Factors

2005